Tuesday, September 29, was supposed to be a banner day for the IPO market. Instead, it became a warning. Smart ring maker Oura shelved its planned $2.2 billion Nasdaq debut, citing "market uncertainty" — and on the same morning, leaked details from AI giant Anthropic's IPO prospectus gave investors their first unvarnished look at the staggering economics of the artificial intelligence race.
Together, the two events tell one story: capital markets are open, but they have become ruthlessly selective. Growth alone is no longer enough — investors want to see the math.
Oura's pause: demand was not the problem
Oura had been marketing 50 million shares at an indicated price range of $40 to $44 apiece, a deal that would have raised $2.2 billion at the top of the range and valued the Finnish-founded consumer technology company at $15.62 billion on a fully diluted basis. Pricing was expected Tuesday, with trading to begin Wednesday. The underwriting syndicate — Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies — read like a who's who of Wall Street.
What makes the postponement striking is that the deal was working. Bloomberg reported that the order book was nearly four times subscribed. This was not a broken IPO; it was a deliberate choice to wait.
Chief Executive Tom Hale framed it exactly that way: "We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment. In the meantime, we will execute against the opportunities ahead."
The stated reason — market uncertainty — is hard to argue with. The Federal Reserve's September rate hike, the prospect of another increase in late October, elevated fuel prices, and Treasury yields at multi-decade highs have clouded the outlook for consumer spending and investor risk appetite alike. Oura's debut would have been the first US IPO to raise more than $1 billion since Jersey Mike's in July, making it a bellwether for the fall listing season.
Oura is not alone in stepping back. Nuclear power services company Holtec Nuclear suspended its planned US listing earlier in the month, and CVC-backed Bamboo Insurance Services also delayed its debut. The pattern suggests growing caution among Wall Street desks about the risk of an equity market reversal as yields surge.
"Higher rates are clearly making investors more selective, particularly on growth valuations," Lukas Muehlbauer, research associate at IPOX Research, told Reuters. "Still, I wouldn't say the IPO window is closed, especially with Anthropic still pushing ahead with what could be one of the largest IPOs ever."
Anthropic's numbers: scale beyond precedent
If Oura's story is about timing, Anthropic's is about scale. Reuters reported Monday on details from the AI company's IPO prospectus, and the figures are difficult to absorb in one sitting:
- Revenue: climbed roughly twelvefold to nearly $4.6 billion in 2025.
- Operating loss: $8.06 billion in 2025.
- Net loss: nearly $42 billion — though roughly $34 billion of that reflects accounting charges tied largely to earlier financing rounds rather than cash burned.
- Future obligations: an eye-watering $518 billion in future cloud, computing, and infrastructure commitments.
- Cash on hand: about $20 billion.
These are not the economics of a software company; they are the economics of a moonshot. The $518 billion in future commitments — data centers, chips, power — represents a bet that demand for frontier AI will grow fast enough to justify infrastructure spending on a scale that rivals national budgets.
The race to go public
Anthropic, the world's most valuable venture-backed startup, has indicated it wants to beat rival OpenAI to the public markets. The company confidentially filed its draft S-1 with the SEC on June 1, 2026, and reports suggest a listing could come as soon as October — with one report putting the potential raise at up to $100 billion at a target valuation of $2 trillion, which would make it the largest IPO in history.
That timeline has already slipped: the public prospectus was expected shortly after Labor Day, and as of late September the SEC's EDGAR database still contained no public filing. Some reporting now points to a listing after the November midterm elections.
OpenAI, meanwhile, is playing a longer game. The company reportedly filed confidentially in June and is now looking toward early 2027. It also scrapped the launch of a new model this week over concerns about its behavior in testing — a reminder that the AI safety debate is live inside the labs, not just in the press.
Investors are watching the Anthropic filing as a live test of whether private-market valuations for leading AI companies can survive public-market scrutiny. A May Series H valued the company at $965 billion; SpaceX, which debuted on Nasdaq in June 2026 at roughly a $2 trillion valuation while raising about $75 billion, set a precedent. One recent analysis projected combined target valuations for SpaceX, Anthropic, and OpenAI at about $5.2 trillion — a number that has sharpened calls for granular disclosure of unit economics before those valuations are judged by public investors.
What it means for the IPO market
The fall listing season was supposed to be the busiest since 2021. Instead, the market is sorting companies into two camps. Those with fortress balance sheets and clear paths to cash flow — the Anthropic-scale bets backed by the world's deepest-pocketed investors — can still push forward. Everyone else is being asked to wait for calmer conditions.
For investors, the lesson of the week is that the bar has moved. Four-times-oversubscribed order books are no longer enough to guarantee a launch when macro uncertainty is this high. And for the AI trade, the prospectus numbers make the stakes explicit: this is a capital race measured in hundreds of billions, and the public markets are about to be asked to fund it.
The IPO window is not shut. But it has narrowed to companies that can afford to be patient — and Oura, sitting on strong demand and a healthy business, just showed that patience can itself be the strategy.
This article is for informational purposes only and is not investment advice. IPOs carry significant risk; consider speaking with a qualified financial professional before making investment decisions.
Sources
